Bitcoin (btc)$83,682.00↑ 0.20%
Ethereum (eth)$2,682.05↑ 0.00%
Tether (usdt)$0.999585↓ 0.01%
BNB (bnb)$766.42↑ 1.10%
XRP (xrp)$1.49↓ 0.65%
USDC (usdc)$0.999798↓ 0.01%
Solana (sol)$117.88↓ 1.11%
TRON (trx)$0.337761↑ 0.88%
Figure Heloc (figr_heloc)$1.028↑ 2.39%
Zcash (zec)$1,414.29↓ 0.01%
Hyperliquid (hype)$91.08↑ 5.72%
Dogecoin (doge)$0.094116↓ 0.17%
Chainlink (link)$14.33↓ 2.62%
Monero (xmr)$540.30↓ 0.84%
WhiteBIT Coin (wbt)$83.56↑ 0.08%
Bitcoin (btc)$83,682.00↑ 0.20%
Ethereum (eth)$2,682.05↑ 0.00%
Tether (usdt)$0.999585↓ 0.01%
BNB (bnb)$766.42↑ 1.10%
XRP (xrp)$1.49↓ 0.65%
USDC (usdc)$0.999798↓ 0.01%
Solana (sol)$117.88↓ 1.11%
TRON (trx)$0.337761↑ 0.88%
Figure Heloc (figr_heloc)$1.028↑ 2.39%
Zcash (zec)$1,414.29↓ 0.01%
Hyperliquid (hype)$91.08↑ 5.72%
Dogecoin (doge)$0.094116↓ 0.17%
Chainlink (link)$14.33↓ 2.62%
Monero (xmr)$540.30↓ 0.84%
WhiteBIT Coin (wbt)$83.56↑ 0.08%

GENEWIZ and Form Bio Launch End-to-End Solution for AAV Gene Therapy Development – Draper Decentralized – 5.20.25

Published May 20, 2025

GENEWIZ and Form Bio have partnered to accelerate AAV gene therapy development by integrating long-read sequencing and genome integrity analysis. The collaboration delivers a streamlined workflow that improves vector safety, design, and manufacturability.